Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Multimodal Physiotherapy for Balance and Vertigo in BPPV Patients

4 de mayo de 2026 actualizado por: Riphah International University

Effects of Multimodal Physiotherapy Approach on Balance, Vertigo, Fear of Fall, and Quality of Life in Patients With Benign Paroxysmal Positional Vertigo

This study aims to evaluate the effects of a multimodal physiotherapy approach on balance, vertigo, fear of falling, and quality of life in patients with benign paroxysmal positional vertigo (BPPV). BPPV is a common vestibular disorder that causes dizziness and balance problems, leading to an increased risk of falls and reduced quality of life. In this randomized controlled trial, participants will be assigned to two groups: one receiving a multimodal physiotherapy program including patient education, Epley maneuver, and balance training, and the other receiving standard Epley maneuver treatment. The intervention will be conducted over four weeks. Outcomes will be assessed using standardized tools for balance, vertigo, fear of falling, and quality of life. The study aims to determine whether a combined physiotherapy approach provides better outcomes than standard treatment alone.

Descripción general del estudio

Descripción detallada

Benign paroxysmal positional vertigo (BPPV) is one of the most common vestibular disorders, characterized by brief episodes of vertigo triggered by changes in head position. It significantly affects balance, mobility, and quality of life, and increases the risk of falls, especially in older adults. Although repositioning maneuvers such as the Epley maneuver are considered the standard treatment, many patients continue to experience residual dizziness, imbalance, and fear of falling.

A multimodal physiotherapy approach that combines patient education, vestibular rehabilitation, and balance training may provide a more comprehensive strategy to address these residual impairments. This approach targets both the vestibular and functional components of recovery, potentially improving overall patient outcomes.

This study is a single-blinded randomized controlled trial designed to evaluate the effects of a multimodal physiotherapy approach compared to standard treatment in patients with BPPV. Participants aged 22 to 79 years diagnosed with BPPV will be recruited using a non-probability convenience sampling technique. Participants will be randomly allocated into two groups: the intervention group receiving patient education, Epley maneuver, and balance training, and the control group receiving only the Epley maneuver. The intervention will be administered three times per week for four weeks.

Outcome measures will include the Dynamic Gait Index for balance, Dizziness Handicap Inventory for vertigo, Falls Efficacy Scale-International for fear of falling, and SF-36 for quality of life. Assessments will be conducted at baseline and after completion of the intervention.

The results of this study will provide evidence on whether a multimodal physiotherapy approach is more effective than standard treatment in improving balance, reducing vertigo symptoms, decreasing fear of falling, and enhancing quality of life in patients with BPPV.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

46

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Punjab Province
      • Faisalabad, Punjab Province, Pakistán
        • Allied Hospital I & II

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

Age group between (22-79). Both the genders Male and Female were included. Diagnosed with posterior canal benign paroxysmal positional vertigo (PC-BPPV) confirmed by a positive Dix-Hall pike maneuver.

Onset of symptoms within the past 3 months. Dynamic Balance impairment by DGI > 21. All patients had history of at least two or more attacks of BPPV over 6 months.

Exclusion Criteria:

Patients with a history of cervical spine injuries. Patients taking anti-vertigo medication. Patients with a previous diagnosis of Meniere's disease, migraine, or vestibular neuritis Patients with a previous history of neurological diseases. Cases with bilateral involvement. Absence of systemic diseases without medical control and absence of functional limitations that impede independent walking.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Multimodal Physiotherapy
participants will receive a multimodal physiotherapy program including patient education, Epley maneuver, and balance training, administered three times per week for four weeks.
A combined rehabilitation approach including vestibular rehabilitation, patient education, and balance training aimed at improving balance, reducing vertigo, decreasing fear of falling, and enhancing quality of life.
Otros nombres:
  • Multimodal Physiotherapy Approach (MPA)
A repositioning technique involving sequential head and body movements to relocate displaced otoconia within the semicircular canals to relieve symptoms of benign paroxysmal positional vertigo.
Comparador activo: epley Maneuver
Participants will receive standard treatment using the Epley maneuver, administered three times per week for four weeks.
A repositioning technique involving sequential head and body movements to relocate displaced otoconia within the semicircular canals to relieve symptoms of benign paroxysmal positional vertigo.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Balance
Periodo de tiempo: Baseline and Week 4
Balance will be assessed using the Dynamic Gait Index (DGI), a validated tool that evaluates gait, stability, and functional mobility in individuals with balance disorders.
Baseline and Week 4

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Wajeeha Zia, phd, Riphah International University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

5 de junio de 2025

Finalización primaria (Estimado)

6 de julio de 2026

Finalización del estudio (Estimado)

6 de agosto de 2026

Fechas de registro del estudio

Enviado por primera vez

4 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

4 de mayo de 2026

Publicado por primera vez (Actual)

8 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

8 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

There is no plan to share individual participant data. All data will be kept confidential and used solely for academic and research purposes.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir